Arvinas
Price & Volume
Stats
See moreOpen | $8.31 |
Previous Close | $8.27 |
Day Range | $8.15-$8.47 |
52W Range | $5.90-$29.61 |
Market Cap | $607.1M |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $372.8M |
Revenue Growth (YoY) | -70.7% |
Gross Profit (12 Mos) | $392M |
Diluted EPS | -$1.01 |
News
See moreYahoo Finance • 5 days ago
Amazon upgraded, Adobe downgraded: Wall Street’s top analyst calls
Yahoo Finance • 6 days ago
Amazon upgraded, Adobe downgraded: Wall Street's top analyst calls
Yahoo Finance • 12 days ago
Arvinas announces $100M share repurchase program
Yahoo Finance • 13 days ago
Arvinas To Cut Jobs, Out-License Vepdegestrant, And Launch $100 Mln Stock Buyback Plan
About
CEO | Dr. John G. Houston Ph.D. |
CFO | Mr. Andrew R. Saik |
Address | 5 Science Park, New Haven, CT, United States, 06511 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 430 |
